| Entry |
|
|---|
| Name |
Zalunfiban (USAN) |
|---|
| Formula |
C16H18N8O2S
|
|---|
| Exact mass |
386.1273
|
|---|
| Mol weight |
386.4315
|
|---|
| Structure |
|
|---|
| Remark |
|
|---|
| Efficacy |
Platelet aggregation inhibitor, Glycoprotein IIb/IIIa receptor antagonist |
|---|
| Comment |
Treatment of ST segment elevated myocardial infarction
|
|---|
| Target |
|
|---|
| Pathway |
|
|---|
| Brite |
Target-based classification of drugs [BR:br08310]
Cell surface molecules and ligands
Cell adhesion molecules: other families
Integrins
ITGA2B/ITGB3
D12051 Zalunfiban (USAN)
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 27
1 N4y N 13.5100 -18.5500
2 C8y C 13.5100 -19.9500
3 N5x N 14.7224 -20.6500
4 C8y C 15.9349 -19.9500
5 C8x C 15.9349 -18.5500
6 C8y C 14.7224 -17.8500
7 O5x O 14.7224 -16.4502
8 N5x N 12.1785 -18.1174
9 C8y C 11.3556 -19.2500
10 S2x S 12.1785 -20.3826
11 C8y C 9.9400 -19.2500
12 C8x C 9.2400 -18.0376
13 N5x N 7.8400 -18.0376
14 C8x C 7.1400 -19.2500
15 C8y C 7.8400 -20.4624
16 C8x C 9.2400 -20.4624
17 N1b N 7.1496 -21.6579
18 C5a C 5.7403 -21.6580
19 O5a O 5.0279 -20.4246
20 C1b C 5.0523 -22.8494
21 N1a N 3.6403 -22.8496
22 N1y N 17.1660 -20.6610
23 C1x C 17.1657 -22.0499
24 C1x C 18.3780 -22.7502
25 N1x N 19.5906 -22.0505
26 C1x C 19.5909 -20.6616
27 C1x C 18.3786 -19.9613
BOND 30
1 1 2 1
2 2 3 2
3 3 4 1
4 4 5 2
5 5 6 1
6 1 6 1
7 6 7 2
8 1 8 1
9 8 9 2
10 9 10 1
11 2 10 1
12 9 11 1
13 11 12 2
14 12 13 1
15 13 14 2
16 14 15 1
17 15 16 2
18 11 16 1
19 15 17 1
20 17 18 1
21 18 19 2
22 18 20 1
23 20 21 1
24 4 22 1
25 22 23 1
26 23 24 1
27 24 25 1
28 25 26 1
29 26 27 1
30 22 27 1
|
|---|
